Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
about
Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013.Epidemiology of invasive mold infections in lung transplant recipientsInvasive fungal infections in solid organ transplant recipients.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicityVoriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.Pharmacotherapy approaches to antifungal prophylaxis.Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis.Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.Voriconazole and squamous cell carcinoma after lung transplantation: a multicenter study.Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.Fungal Infections After Lung Transplantation.Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation.Uptake and efflux kinetics, and intracellular activity of voriconazole against Aspergillus fumigatus in human pulmonary epithelial cells: a new application for the prophylaxis and early treatment of invasive pulmonary aspergillosis.10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient VariabilityRisk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.Preemptive treatment with voriconazole in lung transplant recipients.Voriconazole exposure regulates distinct cell-cycle and terminal differentiation pathways in primary human keratinocytes.Posaconazole liquid vs tablet formulation in lung transplant recipients.Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.Antifungal prophylaxis in pediatric lung transplantation: an international multicenter survey.Squamous cell carcinoma of the skin and voriconazole therapy in lung transplant recipients: a case seriesAn Approach to a Pulmonary Infiltrate in Solid Organ Transplant Recipients
P2860
Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal DiseaseThe Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised ParticipantsBeta Glucan Assay in Patients Receiving Voriconazole ProphylaxisA Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
P921
Q33629045-3953C64B-978A-480D-B186-09F21CB0D20EQ34153644-21BE2561-706E-4261-86D5-3F41C0E232ABQ34461693-81BBB033-27B6-4358-8299-9600523CECD1Q34532546-D1C5A5F6-0D47-44FF-AC9C-BFE0DAC5D9A0Q35941502-F1F90961-B334-4DA5-B399-452BCB89ED47Q36480011-889DECE1-E000-469C-BFA9-42CE2E97AF96Q36658777-BDAFBEB5-C647-465C-ABE8-5304A028E668Q37124182-856A330B-671E-4B3F-9E0A-787B71C8A782Q38020238-D08C1C0D-61D7-4675-9F1B-7F445E5237CCQ38156666-68AA0FD9-FB99-442D-B346-75CA4F08DF25Q38960267-BA43A8A9-1C44-40F0-A5FC-A9D16E508B14Q39027209-29C0111A-D8B3-42D7-B619-05FCACA660A0Q40051243-FC0223D3-08AF-4B6F-AB0F-8E7F1B2C819FQ40093479-E37E7A95-DA03-4142-9618-444BB496D8E7Q40098248-1FE1705C-3FC3-43F3-AC0D-37B32DADBCB3Q40191644-255892B8-18BC-4DE5-80EC-BB6D01B69B6DQ40396776-775B0A29-47EA-4C6B-8E95-6403E4FA8E33Q41015559-94907661-3C3A-44D8-B207-5D5067929DF9Q41284722-106C03F6-D868-4015-8684-FD949C236048Q41522687-F2300BD9-75F3-4F05-9191-3ACB25A863CEQ41532401-0BF95D6D-FB71-4DBC-ACE0-0A5045AC83E2Q41991703-AA8AACA9-4FA4-4C49-A07F-D78E0AEC1782Q42435668-0C1EF156-C783-4212-8A80-AF40E9453D14Q44239236-C45383E5-1ED9-4C0A-9CAA-A1DFE3642BF7Q44997320-8F8A60CB-D8B7-465E-A64D-00732DDB31BAQ48354018-E6C62987-98AF-44E2-BE5B-0DC423F085F5Q50927538-3C9DD578-CF26-4DAB-BA00-D950CBDC330CQ51385199-986C9860-EFE4-4601-BF06-A9F05F1969D1Q53090356-B9FDFE33-9620-4E99-8023-2078B20F5C28Q57746013-5C2DF914-D9BA-4B8D-A19C-223296F045C4Q57746058-6AE5DA6B-74EC-4825-8634-D747EDD366D6
P2860
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
description
im Januar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 January 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2011
@uk
name
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
@en
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
@nl
type
label
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
@en
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
@nl
prefLabel
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
@en
Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey
@nl
P2093
P2860
P50
P1476
Antifungal prophylaxis in lung transplantation--a world-wide survey
@en
P2093
C O Morrissey
T Kotsimbos
P2860
P304
P356
10.1111/J.1600-6143.2010.03375.X
P407
P577
2011-01-10T00:00:00Z